Adlai Nortye Ltd. American Depositary Shares

NASDAQ:ANL

1.45 (USD) • At close August 1, 2025
Bedrijfsnaam Adlai Nortye Ltd. American Depositary Shares
Symbool ANL
Munteenheid USD
Prijs 1.45
Beurswaarde 15,097,835
Dividendpercentage 0%
52-weken bereik 1.1 - 3.89
Industrie Biotechnology
Sector Healthcare
CEO Mr. Yang Lu
Website https://www.adlainortye.com

An error occurred while fetching data.

Over Adlai Nortye Ltd. American Depositary Shares

Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trial for the treatment of recurrent or metastatic head and neck squamous

Vergelijkbare Aandelen

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)